OnKure Therapeutics, Inc.
Recent Filings
All 345 filings →| Form | Description | Date |
|---|---|---|
| 4 | — | Mar 24, 2026 |
| 4 | — | Mar 24, 2026 |
| S-8 | S-8 | Mar 12, 2026 |
| 10-K | 10-K | Mar 12, 2026 |
| 8-K | 8-K | Mar 12, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Jan 30, 2026 |
| 4 | 4 | Jan 2, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Saccomano Nicholas A | President and CEO | Sale | 87 @ $2.97 | 7,419 | Dec 22, 2025 |
| Leverone Jason A. | Chief Financial Officer | Sale | 302 @ $2.97 | 16,301 | Dec 22, 2025 |
| Mathers Edward T | — | Award / Grant | 4,125 | 11,399 | Sep 30, 2025 |
| Manke Isaac | — | Award / Grant | 5,545 | 15,325 | Sep 30, 2025 |
| Saccomano Nicholas A | President and CEO | Sale | 88 @ $2.62 | 3,506 | Sep 22, 2025 |
| Leverone Jason A. | Chief Financial Officer | Sale | 303 @ $2.62 | 12,603 | Sep 22, 2025 |
| Mathers Edward T | — | Award / Grant | 4,694 | 7,274 | Jun 30, 2025 |
| Manke Isaac | — | Award / Grant | 6,311 | 9,780 | Jun 30, 2025 |
| Saccomano Nicholas A | President and CEO | Sale | 88 @ $2.38 | 3,594 | Jun 23, 2025 |
| Leverone Jason A. | Chief Financial Officer | Sale | 303 @ $2.38 | 12,906 | Jun 23, 2025 |